Announcement at International Society of Cardiovascular CT Conference: MDDX Contributes Free Cardiac Reporting Software for Use in Medical Research

New online Coronary CT scoring application standardizes data collection.

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friend
Informatics
“One of the issues we observe in cardiac imaging research is lack of adherence to a standard nomenclature. This application resolves that,” said Dan Gebow, CEO of MDDX.

(PRWEB) July 20, 2012

MDDX, a provider of biomedical research software and services for pharmaceutical, biotechnology and medical device industries today announced the release of Online Coronary CT eCRF. This free application allows medical researchers to characterize coronary plaque via an IPAD or web-enabled computer. MDDX is providing the application at no charge to accelerate disease discovery by standardizing data elements according the guidelines established by the Society of Cardiovascular CT.

MDDX CCTA Report applications have been used in over a dozen global trials for a total of 8,000 patients in 23 different countries. The new online version allows researchers to quickly build databases with only a few clicks. Users can export their database for analysis. Due to the fact that the application is a fully-hosted solution, all web space, security and backups are managed for the user.

“One of the issues we observe in cardiac imaging research is lack of adherence to a standard nomenclature. This application resolves that,” said Dan Gebow, CEO of MDDX. “We are providing this to the research community completely free out of respect for the hard work thousands of cardiac imagers have contributed over the past decade of CCTA research”.

Users can register for the free version at: https://www.mddx.com/ccta/form/

About MDDX
MDDX, LLC (http://www.MDDX.com) provides research services and medical informatics to accelerate biomedical research and patient care. Founded by scientists, physicians and software engineers, MDDX currently assists in research studies in over 20 countries with focuses ranging from coronary artery disease to traumatic brain injury. MDDX is based in San Francisco, CA.

Contact:
David Leflang
Communications Director
MDDX, LLC
Phone +1 800 441 6339
dleflang(at)mddx(dot)com


Contact